CClinicalTrials.gg
CompletedNCT01270022Updated Jan 5, 2011

Development, Implementation and Evaluation of the Impact of a Guideline in Clinical Practise for Cardiovascular Risk

An interventional study of Implementation and dissemination in Cardiovascular Risk Factors, Clinical Practice Guideline and Implementation Strategies, sponsored by Gerencia De Atencion Primaria Area 2 De Madrid. Completed at 1 site in Spain. Open to participants aged 14 Years and older. Per ClinicalTrials.gov, last updated 2011-01-05.

Sponsored by Gerencia De Atencion Primaria Area 2 De Madrid · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Allocation
Randomized
Ages
14 Years and older
Sex
All
01

Study summary

The aim of this study is to evaluate the impact of a clinical guideline in cardiovascular risk, with a local adaptation model of the existing guidelines in clinical practise at present, of each of the different cardiovascular risk factors, and the implementation strategy.

Read the detailed description

With this objective this study will be developed in three diferent phases. The guideline in clinical practice elaboration. It will be based in evidence medicine and it will be adapted based in the cardiovascular risk factors guidelines published at the present.

The spreding and implementation of the guideline between the sanitarians, as much in primary medicine as in specialised area, involved in the care of the patient in cardiovascular risk, in the Area 2 in Madrid.

And the evaluation of the implementation strategy, used between the primary care physicians.

For the local adaptation, will be used a systematic review of the different guidelines in the Spanish and international literature, published in the last years about this topic.

The ones with better quality criteria will be selected and doctors and nurses related from different specialities, involved in the cardiovascular illness, as much as members of the staff of the medical management an nursery, will be invited to participate in the selection of the recommendations of the guides and in the search of the consensus. After that, this guide will be given to a group of patients, who will be asked for a critical approach and their suggestions will be applied.

The evaluation will be done with a clinical trial designe , testing the use of the guide and its results on health intermediary variables. With this objective the results with an implementation technique based on opinion leaders plus computer reminder, will be evaluated, instead of using the standard implementation.

02

Conditions studied

  • Cardiovascular Risk Factors
  • Clinical Practice Guideline
  • Implementation Strategies
  • Primary Care
03

In context

Lead sponsor

This is the only study on the registry with Gerencia De Atencion Primaria Area 2 De Madrid as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • patients whose health cards showed them to belong to the studied health area

Exclusion criteria

Exclusion Criteria:

  • Clinical history have not opened in the health center or this one is empty
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)

Study arms

  • Experimental
    Implementation

    Other: Implementation

  • Active comparator
    dissemination

    Other: dissemination

Interventions

  • OtherImplementation
  • Otherdissemination
06

Study locations

1 site
  • Gerencia de Atención Primaria del área 2
    Madrid, 28009, Spain
07

References and documents

Publications

  • Rodriguez-Salvanes F, Novella B, Fernandez Luque MJ, Sanchez-Gomez LM, Ruiz-Diaz L, Sanchez-Alcalde R, Sierra-Garcia B, Mayayo S, Ruiz-Lopez M, Loeches P, Lopez-Gonzalez J, Gonzalez-Gamarra A; SIRVA2 group. Efficacy of a strategy for implementing a guideline for the control of cardiovascular risk in a primary healthcare setting: the SIRVA2 study a controlled, blinded community intervention trial randomised by clusters. BMC Fam Pract. 2011 Apr 19;12:21. doi: 10.1186/1471-2296-12-21. PubMed 21504570 ↗
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 5, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01270022
Lead sponsor
Gerencia De Atencion Primaria Area 2 De Madrid
Collaborators
Health Research Fund of ISCIII Spain
First posted
Jan 5, 2011
Start date
Jan 2004
Primary completion
Apr 2006
Completion
Jul 2010
Last update
Jan 5, 2011

Study contacts

Blanca Novella, MD. pHD
principal investigator · Gerencia de Atención Primaria del área 2
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion